Protecting patients' privacy and identities when writing compelling, real-life narratives can be difficult, a physician-writer admits in The Atlantic.

In a case that dates back almost a decade, an interventional cardiologist in Louisiana who was convicted of fraud and two other entities have agreed to pay a $650,000 settlement.

A clinical trial investigating the use of a physician-monitored app to help first-time minority stroke patients become healthier has begun at The University of Texas Health Science Center at Houston (UTHealth).

WomenHeart: The National Coalition for Women with Heart Disease today announces Mary McGowan as Chief Executive Officer. McGowan is the third CEO for the nation’s first and still only national organization solely devoted to women’s heart health and supporting the 43 million American women living with or at risk for heart disease. She had served as the organization’s Chief Operating Officer since 2010, immediately prior to assuming the role of CEO.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that new data from two trials of the company’s cardiovascular medicines will be presented at the 2015 American College of Cardiology Annual Scientific Sessions (ACC.15), March 14-16 in San Diego.

Findings published Feb. 24 in JAMA suggest caution may be required when prescribing nonsteroidal anti-inflammatory drugs (NSAIDs) for patients with a recent MI. The population study noted that MI patients taking one or more NSAIDs had increased risk for bleeding compared with patients who weren’t taking them.

Cardiologists who want to improve patient outcomes need to strike a balance between evidence-based therapy and patient safety, according to a study published online Feb. 16 in Circulation.

This could get steamy: By frequently taking saunas, men may reduce their risk of cardiac-related fatalities, according to a study published online Feb. 23 in JAMA Internal Medicine.